Abstract
Nanocellulosic materials, such as cellulose nanocrystals, cellulose nanofibers, and bacterial nanocellulose, that display high surface area, mechanical strength, biodegradability, and tunable surface chemistry have attracted great attention over the last decade for biomedical applications. Simultaneously, 3D printing is revolutionizing the field of biomedical engineering, which enables the fast and on-demand printing of customizable scaffolds, tissues, and organs. Nanocellulosic materials hold tremendous potential for 3D bioprinting due to their printability, their shear thinning behavior, their ability to live cell support and owing to their excellent biocompatibility. The amalgamation of nanocellulose-based feedstocks and 3D bioprinting is therefore of critical interest for the development of advanced functional 3D hydrogels. In this context, this review briefly discusses the most recent key developments and challenges in 3D bioprinting nanocellulose-based hydrogel constructs that have been successfully tested for mammalian cell viability and used in tissue engineering applications.
Keywords: nanocellulose, 3D printing, hydrogels, biocompatibility, tissue engineering
1. Introduction
Hydrogels are three-dimensional (3D) networks of crosslinked hydrophilic polymer chains, which are capable of imbibing large quantities of water [1]. Among polymers of natural origin, cellulose is the most abundant, renewable, inexpensive, and readily available polysaccharide in the world with an annual production of 1011 to 1012 tons [2]. The major sources of cellulose are plant fibers and wood. Cellulose is a linear polymer, consisting of D-anhydroglucose units joined together by β-1,4-glycosidic linkage, that can exist as microfibrils of different crystalline polymorphs (I, II, III and IV) [3]. Cellulose I is the natural or native form of cellulose, which is the crystal structure that has the highest axial elastic modulus, is thermodynamically metastable, and can be converted to either cellulose II or III. Cellulose I is found in two distinct crystal phases: Iα (triclinic), predominantly found in algae and bacteria, and Iβ (monoclinic), predominantly found in bacteria, plants, and tunicates. Cellulose II is the most stable crystal structure of technical relevance and can be produced by the regeneration and mercerization of cellulose I [3].
During biosynthesis, intermolecular hydrogen bonds between hydroxyl and oxygen groups of adjacent molecules; and van der Waals forces promote parallel stacking of multiple cellulose chains, forming stable elementary fibrils with high axial stiffness that further aggregate into larger microfibrils (5–50 nm in diameter and several microns in length), as shown in Figure 1 [3,4,5]. These cellulose fibrils consist of highly ordered (crystalline) and disordered (amorphous-like) regions that are the main reinforcement segment for plants, trees, algae, and some marine creatures and bacteria [3]. Although bacterial cellulose has the same molecular formula as plant cellulose, its macromolecular properties differ from plant cellulose and exhibit characteristic ribbon-like microfibrils [6]. Cellulose-based hydrogels are of wide scientific interest for their applications in multidisciplinary areas, such as agriculture, textiles, energy, biomedical, etc. [7].
Figure 1.
Hierarchical structure of cellulose: top image: plant cellulose; bottom image: bacterial cellulose. Adapted with permission from ref. [5]. Copyright 2014, Elsevier.
Over the last decade, hydrogels made from nanocellulosic materials, such as cellulose nanowhiskers or nanocrystals (CNCs), cellulose nanofibrils or nanofibers (CNFs), and bacterial nanocellulose (BNC) have attracted great attention for biomedical applications owing to their high surface area, high mechanical strength, tunable surface chemistry, excellent biocompatibility, cellular recognition, and biodegradability [8].
2. Nanocellulose: Synthesis, Mechanical Properties, Biodegradation and Biocompatibility
CNCs are highly crystalline needlelike cellulose nanostructures of 10–20 nm in width and several hundred nanometers in length, whereas CNFs and BNC are long, flexible cellulose fibers with a high aspect ratio, and consist of both crystalline and amorphous regions with a fibril diameter similar to, or larger than, CNCs [3]. CNCs and CNFs are largely sourced from plants and trees, whereas BNC is mainly generated by cultured gram-negative bacteria Gluconacetobacter xylinus [5]. CNCs are commonly obtained by strong acid hydrolysis of native cellulose fibers, using sulfuric or hydrochloric acid [4]. CNFs are isolated through high-pressure, high temperature, high velocity impact homogenization, and grinding or the microfluidization process [9]. Lately, (2,2,6,6-Tetramethylpiperidin-1-yl)oxyl (TEMPO)-mediated oxidation coupled with low speed mechanical treatment is becoming increasingly popular for CNF isolation. This method uses the TEMPO radical as a catalyst to selectively oxidize the primary alcohol groups in the cellulose leaving CNFs with a carboxylic acid surface [10]. Conversely, BNC can be produced in a static culture, which results in the accumulation of a thick, white nanocellulose pellicle (Figure 1) at the air–liquid interface and/or stirred culture, which results in dispersed nanocellulose (as irregular pellets or suspended fibers) in the culture medium [6].
Nanocrystalline cellulose with a density of 1.6 g/cm3 has demonstrated a high tensile strength of 7.5–7.7 GPa (twice that of Kevlar fiber), elastic modulus of 110–220 GPa (in the range of steel wire) in the axial direction, and elastic modulus of 10–50 GPa (greater than carbon nanotubes) in the transverse direction [3]. Moreover, the reactive surface (–OH side groups) of nanocellulose facilitates grafting chemical species to achieve different surface properties that facilitate self-assembly, controlled dispersion within a wide range of polymer matrix, controlled particle-matrix and particle-particle bond strength, and directed cellular response [3]. Nanocellulose has been successfully employed as reinforcing agents in many biodegradable polymers and hydrogels owing to their high mechanical strength and tunable surface chemistry properties [11,12,13].
The biodegradation of nanocellulose is commonly performed by cellulolytic microorganisms, which produce enzymes (endoglucanases, cellobiohydrolases, and β-glucosidases) that act together in synergy and catalyze the depolymerization of cellulose [14]. In the typical enzymatic hydrolysis of nanocellulose, endoglucanases and cellobiohydrolases are responsible for degrading cellulose to cellobiose, which is further hydrolyzed to free glucose molecules by β-glucosidases [14,15]. Moreover, γ-irradiation has been reported to induce scission of the long glucan chains, which results in reduced crystallinity and molecular weight, and enhances the degradation rate of nanocellulose [16]. Recently, Singh et al. [17] studied the biodegradation of nanocrystalline cellulose by two environmentally-relevant consortia, and compared it with microcrystalline cellulose. The authors reported that the sulfuric acid hydrolyzed nanocellulose degraded faster than microcrystalline cellulose, and that nanocellulose was more biodegradable, but likely via different pathways.
Evaluation of nanocellulose in both in vitro and in vivo conditions with different cell lines have demonstrated non-immunogenicity and no to low cytotoxicity (in some cases at low concentration) responses. However, CNFs’ surfaces that were modified with polyethyleneimine and cetyl trimethylammonium bromide showed somewhat cytotoxic effects to mouse fibroblast cells. BNC is commonly believed to possess better biocompatibility than other types of nanocellulose, where no foreign body reaction observed when introduced in animals is well demonstrated [5]. Moreover, the cell behaviors have not only been demonstrated to be affected by the hydrogel’s physical and chemical properties, but also by its 3D geometrical structures that mimic the native extracellular matrix (ECM) environment. To date, several approaches including homogenization, cyclic freeze-thaw, free radical polymerization, UV/ion mediated cross-linking and 3D printing have been reported for the preparation of nanocellulose-based hydrogels for biomedical applications [18].
3. 3D Bioprinting Approach for Hydrogel Fabrication
3D printing, also known as additive manufacturing or rapid prototyping, is a process for constructing 3D physical objects from digital models through the successive layer-by-layer deposition of materials such as metals, ceramics, polymers and/or living cells [19]. The two most common technologies used in 3D printing are stereolithography (SLA), where the solid part is produced from liquid or ink by polymerization; and fused deposition modeling (FDM), where a continuous filament of thermoplastic is used to form hardened continuous layers [20].
The applications of 3D printing in the field of biomedical engineering can be divided into four main areas: (i) manufacturing of permanent non-bioactive implants, (ii) fabrication of local bioactive and biodegradable scaffolds, (iii) manufacturing pathological organ models to aid preoperative planning and surgical treatment analysis, and (iv) direct 3D printing of tissues and organs with complete life functions [20].
Lately, the term ‘3D bioprinting’ has been increasingly used, which refers to the 3D printing of structures using biocompatible inks (commonly called bio-inks); consisting of biomaterials to be fabricated, living cells, and essential nutrients [21,22]. 3D bioprinting of hydrogels generally follows three steps: (i) design or creation of the model, (ii) printing using bio-inks and (iii) in-situ and/or a post-printing cross-linking process to stabilize the printed structures [23]. A schematic of 3D printing for nanocellulose-based hydrogels is shown in Figure 2. Printability of the ink through the micro nozzle is an important factor that governs the quality of the fabricated structures, and is characterized by the ink’s rheological properties to flow and maintain its printed shape, preventing single filament deformation [19]. Moreover, biocompatible inks that can crosslink at body temperature in a short time, with a low photoinitiator concentration and/or requiring low intensity UV light are generally considered attractive materials for 3D bioprinting [24,25].
Figure 2.
Schematic of the 3D printing process and the two-step crosslinking strategy of nanocellulose hydrogels. Adapted with permission from ref. [26]. Copyright 2018, The Royal Society of Chemistry.
4. 3D Bioprinted Nanocellulose-Based Hydrogels: Properties and Biomedical Applications
Although research activities involving nanocellulose have grown exponentially over the last decade, 3D printing of nanocellulose-based materials is still in its infancy (Figure 3A). This section highlights the recent (last five years) developments and challenges in the 3D bioprinting of nanocellulose-based hydrogels, and the in vitro and in vivo tissue engineering applications of the resultant printed constructs. The ink preparation methods, 3D printing conditions, crosslinking methods, mechanical properties, biodegradability, cellular viability; and attachment and proliferation of the printed objects are discussed wherever possible.
Figure 3.
(A) Illustration of the annual number of scientific publications using the search terms “Nanocellulose”, “3D printing cellulose”, and “3D printing nanocellulose”. Data analysis was completed using Scopus search system on 28 March 2019. (B) Different types of cell lines demonstrated for viability and proliferation on 3D bioprinted nanocellulose-based hydrogels.
3D printing of geometrically stable, pristine nanocellulose hydrogels that also remain stable after drying still remains a challenge [25]. At low concentrations (1–2%), CNFs are able to entangle with each other to form hydrogel networks that have crucial properties of a 3D printable ink, such as shear thinning (non-Newtonian behavior of fluids whose viscosity decreases under shear strain), strong thickening and sufficiently high yield stress [27]. Moreover, the introduction of charged functional groups to the CNF interface makes the colloidal stability of CNF-based hydrogels very high and it keeps inks viable for a long time [28]. On the other hand, CNC-reinforced inks, designed for 3D printing, may offer advantages over the semi crystalline CNFs because higher solid loadings may be achieved at a given viscosity and storage modulus due to the absence of physical entanglements [29]. To date, there are only a few reports that have successfully demonstrated both 3D printing and mammalian cell viability and proliferation on the resultant printed stable pristine CNF hydrogels. One of the successful methods involved the 3D-printing of TEMPO-oxidized CNF hydrogel scaffolds based on double network cross-linking; first, by in situ CaCl2 cross-linking and, second, by post-printing chemical cross-linking with 1,4-butanediol diglycidyl ether. Scaffolds were successfully printed from 1 wt % CNF ink, and the mechanical strength of the 3D-printed hydrogels was tunable in the range of 3 to 8 kPa [26]. Cytocompatibility tests demonstrated that the fabricated scaffolds supported human dermal fibroblast cells proliferation, which improved with increasing scaffold rigidity [26]. However, there is a paucity of reports available on successful 3D printing and mammalian cell viability tests on stable pristine CNC and BNC hydrogels.
In order to improve the printability (rheological properties) of nanocellulose-based inks and printed shape fidelity, ink formulations using auxiliary materials, such as naturally-derived polymers, including alginates, hyaluronic acid, gelatin, etc., have been applied [25,30]. Moreover, auxiliary materials can also improve the performance of formed composite hydrogels through particle-polymer interfacial interactions (electrostatic, van der Waals force, and hydrogen and covalent bonds) and energy dissipation [31]. A summary of 3D-printed nanocellulose-based hydrogels and their mammalian cell viability (Figure 3B) are provided in Table 1.
Table 1.
Summary of 3D-printed nanocellulose-based hydrogels; their printing and crosslinking conditions, properties, and biomedical applications.
Hydrogel Composition | Bioink | 3D Printing Feed Rate; Nozzle Size; and Pressure | Crosslinking Condition | Mechanical/Electrical Properties | Mammalian Cell Biocompatibility | Biomedical Application | Ref. |
---|---|---|---|---|---|---|---|
CNF | No | 8 mm/s; 0.20 mm; 50 kPa | 0.01% 1,4-butanediol diglycidyl ether; 50 °C; 2 h | Compressive Young’s moduli: 3.45–7.44 kPa | Human fibroblast cells | Wound healing | [26] |
CNF/alginate (90/10, 80/20, 70/30, 60/40) | Yes | 5–20 mm/s; 0.30 mm; 20–60 kPa | 90 mM CaCl2; 10 min | Compressive stress: 22–33 kPa at 30% strain | Human chondrocyte cells; viability—73% (Day 1), 86% (Day 7) | Cartilage tissue engineering | [33] |
CNF/alginate (2/0.5) | Yes | 5 mm/s; 0.15 mm; 4 kPa | 100 mM CaCl2; 10 min | - | Human and rabbit chondrocyte cells; viability—96% (human), 99% (rabbit) | Cartilage tissue engineering | [34] |
CNF/alginate (CELLINK Bioink, Sweden) | Yes | - | 100 mM CaCl2; 5 min | Compressive stress: 15–39 kPa at 40% strain | Human chondrocyte and mesenchymal stem cells | Tissue engineering | [35] |
CNF/alginate (1.36/1); CNF/alginate sulfate (1.36/0.5) | Yes | 0.16–0.41 mm; 6–74 kPa | 100 mM CaCl2; 12 min | Shear storage modulus: 14.6 kPa | Bovine chondrocyte cells; viability > 85% | Cartilage tissue engineering | [37] |
CNF/alginate (80/20); CNF/hyaluronan (80/20, 70/30) | Yes | 17–20 kPa | CNF/alginate—100 mM CaCl2; 10 min; CNF/hyaluronan—0.001% H2O2; 5 min | Compression stress: 19–55 kPa at 40% strain | Mouse mesenchymal stem cells; viability—95% (Day 7) | Tissue engineering | [39] |
CNF/alginate (60/40); CNF/hyaluronan (80/20) | Yes | 10–20 mm/s; 0.30 mm; 20–30 kPa | CNF/alginate—100 mM CaCl2; 5 min; CNF/hyaluronan—0.001% H2O2; 5 min | - | Human pluripotent stem cells | Cartilage tissue engineering | [40] |
CNF/carbon nanotube (80/20) | No | 10 mm/s; 0.30 mm; 65 kPa | - | Conductivity: 3.8 × 10−1 S/cm | Human neuroblastoma cells; viability > 95% | Neural tissue engineering | [27] |
CNF/polyurethane (9/29) | No | 7–10 mm/s; 0.16 mm and 0.21 mm; 50–200 kPa | - | Compression storage modulus: 1.57 MPa | Mouse and human fibroblast cells | Tissue engineering | [41] |
CNF/gelatin methacrylate (5/1, 2/1, 9/10) | No | 16–33 mm/s; 0.16 mm and 0.21 mm; 65–80 kPa | 0.5% Irgacure 2959; 10 mW/cm2 UV (320–390 nm); 5 min | Compressive Young’s moduli: 2.5–5 kPa | Mouse fibroblast cells; viability > 90% | Wound healing | [42] |
CNF/galactoglucomannan methacrylate (1/1, 1/2, 1/3) | No | 5 mm/s; 0.21 mm | 0.5% Irgacure 2959; 10 mW/cm2 UV (320–390 nm); 5 min | Compressive Young’s moduli: 2.5–22.5 kPa | Human dermal fibroblast and pancreatic tumor cells; viability > 80% (fibroblast), > 60% (pancreatic) | Tissue engineering | [43] |
CNC/gelatin | No | 5–15 mm/s; 0.21 mm and 0.41 mm | 4 °C and 20 °C; 0.25–24 h | Compressive yield deformation at 20% strain | Mouse fibroblast cells | Tissue engineering | [44] |
CNC/alginate (1/1, 1/2, 2/1, 3/2) | Yes | 25 mm/s; 0.11 mm; 34–172 kPa | 1% CaCl2; 10 min | Shear storage moduli: 8–300 Pa | Mouse fibroblast and human hepatoma cells; viability—71% (fibroblast), 67% (hepatoma) | Tissue engineering | [45] |
CNC/alginate (4/1); CNF/alginate (4/1); CNC-CNF/alginate (4/1); | Yes | 0.61 mm | 0.5–1 M CaCl2; 2–4 min | Compressive Young’s modulus: 52.6 kPa | Human chondrocyte cells; viability > 71% | Cartilage tissue engineering | [46] |
Among natural polymers used in bio-ink formulation; alginate, a low-cost polysaccharide is the most widely used auxiliary material that has demonstrated excellent printability, biocompatibility, and ionic (Ca2+) cross-linking functionality [32]. In 2015, Markstedt et al. [33] successfully 3D bioprinted a human ear and sheep meniscus shaped structures using bio-inks containing CNF/alginate blends (90/10, 80/20, 70/30, 60/40) and human chondrocytes (Figure 4). The 3D bioprinted structures were cross-linked by CaCl2 and the cross-linking properties were reportedly controlled by varying the proportion of alginate to CNFs without influencing the viscosity; and hence, the printability. The authors also reported an increase in cell viability in the printed constructs after 7 days compared to Day 1 [33]. Martínez et al. [34] 3D bioprinted CaCl2 cross-linked auricular and lattice-structured constructs from bio-inks containing a CNF/alginate blend (2/0.5) and human nasal chondrocytes (hNCs) or rabbit auricular chondrocytes (rACs). The cell-laden constructs exhibited an increase in cell viability and proliferation during in vitro culture (28 days), and supported the redifferentiation of hNCs and neo-synthesis of cartilage-specific extracellular matrix components. In vivo chondrogenesis in a 3D bioprinted human cell-laden hydrogel construct cross-linked by CaCl2 has been demonstrated by Möller et al. [35]. The cell-laden construct was fabricated from a commercial bio-ink (CELLINK Bioink, Sweden) containing CNFs and alginate. Three groups of printed constructs, encompassing (1) hNCs, (2) human bone marrow–derived mesenchymal stem cells (hBMSCs), and (3) co-culture of hNCs and hBMSCs (20/80) were tested against cell-free scaffolds. The constructs demonstrated compressive stress in the range of 15–39 kPa at 40% strain and maintained their structural integrity after 60 days of implantation. Among the tested group, the co-cultured group showed a more pronounced cell proliferation and enhanced deposition of human collagen II, promising a future application in reconstructive surgery [35].
Figure 4.
(A) Line width measurements of 3D-printed large grids with alginate inks: (i) 2% alginate, (ii) 3% alginate, and (iii) 4% alginate, compared to (iv) Ink9010 (2.25% CNFs + 0.25% alginate). The photos below the graph show the printed grids and their different line resolutions. Small grid printed with (B) 3D printed human ear and (C,D) sheep meniscus with Ink8020 (2% CNFs + 0.5% alginate). (C) Side view and (D) top view of the sheep meniscus. Adapted with permission from ref. [33]. Copyright 2015, American Chemical Society.
Lately, hydrogels made from alginate sulfate have been shown to promote chondrocyte proliferation while maintaining the expression of chondrogenic markers [36]. Müller et al. [37] compared the 3D bioprinting and bovine chondrocyte cell viability of CNF/alginate sulfate (1.36/0.5) with that of CNF/alginate (1.36/1) bio-ink. CNF/alginate sulfate were 3D printed with high shape fidelity and cross-linked with CaCl2. The CNF/alginate sulfate hydrogel discs showed reduced viability values at Day 1, which was suspected due to a yet unknown interaction between CNF and alginate sulfate to exhibit negative side effects. However, the cell viability of hydrogels improved to the same levels as the other conditions at Day 28 and showed mitogenic and collagen II synthesis [37].
Hyaluronic acid (HA) or hyaluronan, one of the chief components of the extra-cellular matrix (ECM), is an anionic, nonsulfated glycosaminoglycan widely used in the design of engineered hydrogels due to its biofunctionality [38]. Recently, Henriksson et al. [39] compared the 3D bioprinting and mouse mesenchymal stem cell viability of CNF/HA (80/20) with that of CNF/alginate (80/20) bio-ink. The CNF/HA construct was crosslinked by H2O2, whereas the CNF/alginate construct was crosslinked by CaCl2. The 3D bioprinted scaffolds showed excellent cell viability (95%) with compression stress in the range of 19–55 kPa at 40% strain. Moreover, the gene expression of the adipogenic marker genes increased 2.0–2.2 fold for cells in the 3D bioprinted constructs when compared with 2D cultured cells [39]. The potential of the systems have also been demonstrated for human pluripotent stem cells (iPSCs) [40].
Conductive CNF/carbon nanotube (80/20) ink used for 3D printing of neural tissue engineering scaffolds was first reported by Kuzmenko et al. [27]. The 3D printed conductive guidelines exhibited an electrical conductivity of 3.8 × 10−1 S/cm, upon which the neural cells preferred to attach, proliferate and differentiate.
Polyurethane (PU), a high performance elastomer, has also been successfully used to 3D print CNF/PU (9/29) biocomposite hydrogel [41]. Transmission electron microscopy images of the construct revealed a ‘skewer-like’ structure, where CNFs were linked to multiple PU nanoparticles. The 3D-printed hydrogels exhibited a compression storage modulus of ~1.57 MPa and demonstrated mouse and human fibroblast cell proliferation [41].
Recently, Xu et al. [42,43] demonstrated 3D printing and UV cross-linking of CNF-based inks containing methacrylate derivatives. The CNF/gelatin methacrylate (GelMA) and the CNF/galactoglucomannan methacrylate (GGM) systems were crosslinked with the help of a photoinitiator, Irgacure 2959. The 3D-printed hydrogels demonstrated a compressive Young’s moduli in the range of 2.5–22.5 kPa. The CNF/GelMA system showed mouse fibroblast cell proliferation and viability >90% (Figure 5) [42] and the CNF/GGM system showed human dermal fibroblast and pancreatic tumor cell viability >80% and >60%, respectively [43]. These systems can potentially be applied for wound healing.
Figure 5.
Mouse fibroblast cells were incubated with the indicated 3D matrix in a density of 1 × 105 cells per well. (a) The cell proliferation and (b) representative confocal images were measured after 3 days of incubation. Scale bar, 50 μm. Bar = mean ± SD; n = 4. * = p < 0.1; ** = p < 0.01. Matrix hydrogels presenting inks of CNF and CNF/GelMA with weight compositional ratios of 5:1, 2:1, and 9:10. Adapted with permission from ref. [42]. Copyright 2019, American Chemical Society.
Compared to CNF-based systems, the 3D printing of CNC-based composite hydrogels has been less explored. This may be due to the poor shear thinning and gelling properties of CNCs relative to CNFs. Xu et al. [44] exploited the temperature responsiveness of gelatin to 3D print CNC/gelatin composite inks. The fabricated hydrogels demonstrated compressive yield deformation at 20% strain and mouse fibroblast cell viability showed potential for soft tissue regeneration. Wu et al. [45] successfully 3D bioprinted a liver-mimetic honeycomb 3D structure using bio-inks containing CNC/alginate (1/1, 1/2, 2/1, 3/2) and either mouse fibroblast or human hepatoma cells. The bio-ink showed excellent shear-thinning property, extrudability and shape fidelity after deposition. The deposited structures were crosslinked with CaCl2 and incubated and cultured for 3 days. The fabricated hydrogels demonstrated shear storage moduli in the range of 8–300 Pa, and cellular viability >67%.
Recently, Jessop et al. [46] demonstrated 3D bioprinting using a unique blend consisting of CNFs, CNCs, and alginate. This unique blend, bioprinted with human nasoseptal chondrocytes, exhibited nano- and micro-roughness for cellular survival and differentiation, as well as maintaining the most stable construct volume in culture. The 3D bioprinted construct that crosslinked with CaCl2 exhibited a compressive Young’s modulus of ~52.6 kPa, and cell viability >71%. Moreover, the chondrocytes demonstrated high metabolic activity post-printing and adopted a rounded chondrogenic phenotype after prolonged culture [46]. However, there is no report available on 3D printing using BNC-based inks.
5. Conclusions and Future Perspectives
Nanocellulose, owing to their high surface area, superior strength, tunable surface chemistry, biodegradability, biocompatibility and promotion of cellular interactions and tissue development has emerged as a new generation of nanomaterial for biomedical application. The application of nanocellulose in the 3D bioprinting of cell-laden hydrogels is relatively new and needs further development in terms of specific technical, material and cellular aspects of the process. The process of 3D bioprinting nanocellulose-based hydrogels for tissue engineering and regeneration applications currently involves either the printing of bio-ink and in-situ cross-linking/post-stabilization of printed structure or the printing of stable geometries and post-cell seeding. However, the in vivo degradability of nanocellulose-based scaffolds still remains a challenge as nanocellulose itself does not completely degrade in the human body due to the lack of relevant enzymes [47]. This needs to be addressed as the degradation of a fabricated scaffold after implantation is important to enhance the interaction between host tissues and those encapsulated in the scaffold. A variety of nanocellulose-based bio-inks containing biopolymers, such as alginate, hyaluronic acid, gelatin and mammalian cells, such as chondrocytes, mesenchymal stem cells, fibroblast, etc., have been successfully demonstrated for the 3D bioprinting of nanocellulose-based functional hydrogels. The addition of biopolymers improves the printability, performance and biodegradation of fabricated constructs; and also broadens their biomedical application, including drug delivery and self-healing. It should be noted that the majority of reports are based on bio-inks prepared using CNFs, alginate and chondrocyte cells, owing to the advantage of the shear thinning and gelling properties of CNF/alginate at low concentrations. However, the considerable increase in viscosity of bio-ink with the increase in CNF concentration is a limiting factor. In comparison, viscoelastic bio-inks prepared with high CNC concentrations enabled 3D printing of textured composites with enhanced stiffness along the printing direction [29]. However, the effects of osmolarity caused by high concentration and shear-induced alignment of CNCs on cell viability during 3D bioprinting need to be studied in detail with caution. Moreover, characteristic ribbon-like fibril formation with higher crystalline structure and hydrophilicity that affect the solution viscosity of 3D printing BNC need to be addressed. Nevertheless, further advances in preclinical animal trials are still required to broaden the utilization of nanocellulose-based 3D bioprinted commercial products for tissue engineering and wound healing applications.
Acknowledgments
The authors thank the Australian Research Council (ARC) for for financial support through the Discovery Grant funding (DP160101267).
Abbreviations
3D | three-dimensional |
CNC | cellulose nanocrystal |
CNF | cellulose nanofiber |
BNC | bacterial nanocellulose |
TEMPO | (2,2,6,6-Tetramethylpiperidin-1-yl)oxyl |
ECM | extra-cellular matrix |
hNCs | human nasal chondrocytes |
rACs | rabbit auricular chondrocytes |
hBMSCs | human bone marrow–derived mesenchymal stem cells |
HA | hyaluronic acid |
iPSCs | human pluripotent stem cells |
PU | polyurethane |
GM | gelatin methacrylate |
GGM | galactoglucomannan methacrylate |
Author Contributions
S.S.A. and R.B. wrote the paper. N.K.D. and N.R.C. revised the paper.
Conflicts of Interest
The authors declare no conflict of interest.
References
- 1.Ahmed E.M. Hydrogel: Preparation, characterization, and applications: A review. J. Adv. Res. 2015;6:105–121. doi: 10.1016/j.jare.2013.07.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Shaghaleh H., Xu X., Wang S. Current progress in production of biopolymeric materials based on cellulose, cellulose nanofibers, and cellulose derivatives. RSC Adv. 2018;8:825–842. doi: 10.1039/C7RA11157F. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Moon R.J., Martini A., Nairn J., Simonsen J., Youngblood J. Cellulose nanomaterials review: Structure, properties and nanocomposites. Chem. Soc. Rev. 2011;40:3941–3994. doi: 10.1039/c0cs00108b. [DOI] [PubMed] [Google Scholar]
- 4.Trache D., Hussin M.H., Haafiz M.K.M., Thakur V.K. Recent progress in cellulose nanocrystals: Sources and production. Nanoscale. 2017;9:1763–1786. doi: 10.1039/C6NR09494E. [DOI] [PubMed] [Google Scholar]
- 5.Lin N., Dufresne A. Nanocellulose in biomedicine: Current status and future prospect. Eur. Polym. J. 2014;59:302–325. doi: 10.1016/j.eurpolymj.2014.07.025. [DOI] [Google Scholar]
- 6.Jozala A.F., de Lencastre-Novaes L.C., Lopes A.M., de Carvalho Santos-Ebinuma V., Mazzola P.G., Pessoa A., Jr., Grotto D., Gerenutti M., Chaud M.V. Bacterial nanocellulose production and application: A 10-year overview. Appl. Microbiol. Biotechnol. 2016;100:2063–2072. doi: 10.1007/s00253-015-7243-4. [DOI] [PubMed] [Google Scholar]
- 7.Kabir S.M.F., Sikdar P.P., Haque B., Bhuiyan M.A.R., Ali A., Islam M.N. Cellulose-based hydrogel materials: Chemistry, properties and their prospective applications. Prog. Biomater. 2018;7:153–174. doi: 10.1007/s40204-018-0095-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Curvello R., Raghuwanshi V.S., Garnier G. Engineering nanocellulose hydrogels for biomedical applications. Adv. Colloid Interface Sci. 2019;267:47–61. doi: 10.1016/j.cis.2019.03.002. [DOI] [PubMed] [Google Scholar]
- 9.Menon M.P., Selvakumar R., Suresh kumar P., Ramakrishna S. Extraction and modification of cellulose nanofibers derived from biomass for environmental application. RSC Adv. 2017;7:42750–42773. doi: 10.1039/C7RA06713E. [DOI] [Google Scholar]
- 10.Isogai A., Saito T., Fukuzumi H. Tempo-oxidized cellulose nanofibers. Nanoscale. 2011;3:71–85. doi: 10.1039/C0NR00583E. [DOI] [PubMed] [Google Scholar]
- 11.Jorfi M., Foster E.J. Recent advances in nanocellulose for biomedical applications. J. Appl. Polym. Sci. 2015;132 doi: 10.1002/app.41719. [DOI] [Google Scholar]
- 12.Kargarzadeh H., Huang J., Lin N., Ahmad I., Mariano M., Dufresne A., Thomas S., Gałęski A. Recent developments in nanocellulose-based biodegradable polymers, thermoplastic polymers, and porous nanocomposites. Prog. Polym. Sci. 2018;87:197–227. doi: 10.1016/j.progpolymsci.2018.07.008. [DOI] [Google Scholar]
- 13.DeFrance K.J., Hoare T., Cranston E.D. Review of hydrogels and aerogels containing nanocellulose. Chem. Mater. 2017;29:4609–4631. doi: 10.1021/acs.chemmater.7b00531. [DOI] [Google Scholar]
- 14.Aubert J.-P., Béguin P. The biological degradation of cellulose. FEMS Microbiol. Rev. 1994;13:25–58. doi: 10.1111/j.1574-6976.1994.tb00033.x. [DOI] [PubMed] [Google Scholar]
- 15.Yeoman C.J., Han Y., Dodd D., Schroeder C.M., Mackie R.I., Cann I.K.O. Advances in Applied Microbiology. Volume 70. Academic Press; New York, NY, USA: 2010. Chapter 1—Thermostable enzymes as biocatalysts in the biofuel industry; pp. 1–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Czaja W., Kyryliouk D., DePaula C.A., Buechter D.D. Oxidation of γ-irradiated microbial cellulose results in bioresorbable, highly conformable biomaterial. J. Appl. Polym. Sci. 2014;131 doi: 10.1002/app.39995. [DOI] [Google Scholar]
- 17.Singh G., Chandoha-Lee C., Zhang W., Renneckar S., Vikesland P.J., Pruden A. Biodegradation of nanocrystalline cellulose by two environmentally-relevant consortia. Water Res. 2016;104:137–146. doi: 10.1016/j.watres.2016.07.073. [DOI] [PubMed] [Google Scholar]
- 18.Du H., Liu W., Zhang M., Si C., Zhang X., Li B. Cellulose nanocrystals and cellulose nanofibrils based hydrogels for biomedical applications. Carbohydr. Polym. 2019;209:130–144. doi: 10.1016/j.carbpol.2019.01.020. [DOI] [PubMed] [Google Scholar]
- 19.Bhatia S.K., Ramadurai K.W. 3-dimensional device fabrication: A bio-based materials approach. In: Bhatia S.K., Ramadurai K.W., editors. 3D Printing and Bio-Based Materials in Global Health: An Interventional Approach to the Global Burden of Surgical Disease in Low- and Middle-Income Countries. Springer International Publishing; Cham, Switzerland: 2017. pp. 39–61. [Google Scholar]
- 20.Yan Q., Dong H., Su J., Han J., Song B., Wei Q., Shi Y. A review of 3D printing technology for medical applications. Engineering. 2018;4:729–742. doi: 10.1016/j.eng.2018.07.021. [DOI] [Google Scholar]
- 21.Hospodiuk M., Dey M., Sosnoski D., Ozbolat I.T. The bioink: A comprehensive review on bioprintable materials. Biotechnol. Adv. 2017;35:217–239. doi: 10.1016/j.biotechadv.2016.12.006. [DOI] [PubMed] [Google Scholar]
- 22.Donderwinkel I., van Hest J.C.M., Cameron N.R. Bio-inks for 3D bioprinting: Recent advances and future prospects. Polym. Chem. 2017;8:4451–4471. doi: 10.1039/C7PY00826K. [DOI] [Google Scholar]
- 23.Maiti B., Díaz Díaz D. 3D printed polymeric hydrogels for nerve regeneration. Polymers. 2018;10:1041. doi: 10.3390/polym10091041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Sultan S., Siqueira G., Zimmermann T., Mathew A.P. 3D printing of nano-cellulosic biomaterials for medical applications. Curr. Opin. Biomed. Eng. 2017;2:29–34. doi: 10.1016/j.cobme.2017.06.002. [DOI] [Google Scholar]
- 25.Xu W., Wang X., Sandler N., Willför S., Xu C. Three-dimensional printing of wood-derived biopolymers: A review focused on biomedical applications. ACS Sustain. Chem. Eng. 2018;6:5663–5680. doi: 10.1021/acssuschemeng.7b03924. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Xu C., Molino B.Z., Wang X., Cheng F., Xu W., Molino P., Bacher M., Su D., Rosenau T., Willför S., et al. 3D printing of nanocellulose hydrogel scaffolds with tunable mechanical strength towards wound healing application. J. Mater. Chem. B. 2018;6:7066–7075. doi: 10.1039/C8TB01757C. [DOI] [PubMed] [Google Scholar]
- 27.Kuzmenko V., Karabulut E., Pernevik E., Enoksson P., Gatenholm P. Tailor-made conductive inks from cellulose nanofibrils for 3D printing of neural guidelines. Carbohydr. Polym. 2018;189:22–30. doi: 10.1016/j.carbpol.2018.01.097. [DOI] [PubMed] [Google Scholar]
- 28.Fall A.B., Lindström S.B., Sundman O., Ödberg L., Wågberg L. Colloidal stability of aqueous nanofibrillated cellulose dispersions. Langmuir. 2011;27:11332–11338. doi: 10.1021/la201947x. [DOI] [PubMed] [Google Scholar]
- 29.Siqueira G., Kokkinis D., Libanori R., Hausmann M.K., Gladman A.S., Neels A., Tingaut P., Zimmermann T., Lewis J.A., Studart A.R. Cellulose nanocrystal inks for 3D printing of textured cellular architectures. Adv. Funct. Mater. 2017;27:1604619. doi: 10.1002/adfm.201604619. [DOI] [Google Scholar]
- 30.Liu F., Chen Q., Liu C., Ao Q., Tian X., Fan J., Tong H., Wang X. Natural polymers for organ 3D bioprinting. Polymers. 2018;10:1278. doi: 10.3390/polym10111278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Nascimento D.M., Nunes Y.L., Figueirêdo M.C.B., DeAzeredo H.M.C., Aouada F.A., Feitosa J.P.A., Rosa M.F., Dufresne A. Nanocellulose nanocomposite hydrogels: Technological and environmental issues. Green Chem. 2018;20:2428–2448. doi: 10.1039/C8GC00205C. [DOI] [Google Scholar]
- 32.Axpe E., Oyen M.L. Applications of alginate-based bioinks in 3D bioprinting. Int. J. Mol. Sci. 2016;17:1976. doi: 10.3390/ijms17121976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Markstedt K., Mantas A., Tournier I., Martínez Ávila H., Hägg D., Gatenholm P. 3D bioprinting human chondrocytes with nanocellulose–alginate bioink for cartilage tissue engineering applications. Biomacromolecules. 2015;16:1489–1496. doi: 10.1021/acs.biomac.5b00188. [DOI] [PubMed] [Google Scholar]
- 34.Ávila H.M., Schwarz S., Rotter N., Gatenholm P. 3D bioprinting of human chondrocyte-laden nanocellulose hydrogels for patient-specific auricular cartilage regeneration. Bioprinting. 2016;1–2:22–35. doi: 10.1016/j.bprint.2016.08.003. [DOI] [Google Scholar]
- 35.Möller T., Amoroso M., Hägg D., Brantsing C., Rotter N., Apelgren P., Lindahl A., Kölby L., Gatenholm P. In vivo chondrogenesis in 3D bioprinted human cell-laden hydrogel constructs. Plast. Reconstr. Surg. Glob. Open. 2017;5:e1227. doi: 10.1097/GOX.0000000000001227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Mhanna R., Kashyap A., Palazzolo G., Vallmajo-Martin Q., Becher J., Möller S., Schnabelrauch M., Zenobi-Wong M. Chondrocyte culture in three dimensional alginate sulfate hydrogels promotes proliferation while maintaining expression of chondrogenic markers. Tissue Eng. Part A. 2013;20:1454–1464. doi: 10.1089/ten.tea.2013.0544. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Müller M., Öztürk E., Arlov Ø., Gatenholm P., Zenobi-Wong M. Alginate sulfate–nanocellulose bioinks for cartilage bioprinting applications. Ann. Biomed. Eng. 2017;45:210–223. doi: 10.1007/s10439-016-1704-5. [DOI] [PubMed] [Google Scholar]
- 38.Highley C.B., Prestwich G.D., Burdick J.A. Recent advances in hyaluronic acid hydrogels for biomedical applications. Curr. Opin. Biotechnol. 2016;40:35–40. doi: 10.1016/j.copbio.2016.02.008. [DOI] [PubMed] [Google Scholar]
- 39.Henriksson I., Gatenholm P., Hägg D.A. Increased lipid accumulation and adipogenic gene expression of adipocytes in 3D bioprinted nanocellulose scaffolds. Biofabrication. 2017;9:015022. doi: 10.1088/1758-5090/aa5c1c. [DOI] [PubMed] [Google Scholar]
- 40.Nguyen D., Hägg D.A., Forsman A., Ekholm J., Nimkingratana P., Brantsing C., Kalogeropoulos T., Zaunz S., Concaro S., Brittberg M., et al. Cartilage tissue engineering by the 3D bioprinting of ips cells in a nanocellulose/alginate bioink. Sci. Rep. 2017;7:658. doi: 10.1038/s41598-017-00690-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Chen R.-D., Huang C.-F., Hsu S.-H. Composites of waterborne polyurethane and cellulose nanofibers for 3D printing and bioapplications. Carbohydr. Polym. 2019;212:75–88. doi: 10.1016/j.carbpol.2019.02.025. [DOI] [PubMed] [Google Scholar]
- 42.Xu W., Molino B.Z., Cheng F., Molino P.J., Yue Z., Su D., Wang X., Willför S., Xu C., Wallace G.G. On low-concentration inks formulated by nanocellulose assisted with gelatin methacrylate (gelma) for 3D printing toward wound healing application. ACS Appl. Mater. Interfaces. 2019;11:8838–8848. doi: 10.1021/acsami.8b21268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Xu W., Zhang X., Yang P., Långvik O., Wang X., Zhang Y., Cheng F., Österberg M., Willför S.M., Xu C. Surface engineered biomimetic inks based on uv cross-linkable wood biopolymers for 3D printing. ACS Appl. Mater. Interfaces. 2019;11:12389–12400. doi: 10.1021/acsami.9b03442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Xu X., Zhou J., Jiang Y., Zhang Q., Shi H., Liu D. 3D printing process of oxidized nanocellulose and gelatin scaffold. J. Biomater. Sci. Polym. Ed. 2018;29:1498–1513. doi: 10.1080/09205063.2018.1472450. [DOI] [PubMed] [Google Scholar]
- 45.Wu Y., Lin Z.Y., Wenger A.C., Tam K.C., Tang X. 3D bioprinting of liver-mimetic construct with alginate/cellulose nanocrystal hybrid bioink. Bioprinting. 2018;9:1–6. doi: 10.1016/j.bprint.2017.12.001. [DOI] [Google Scholar]
- 46.Jessop Z.M., Al-Sabah A., Gao N., Kyle S., Thomas B., Badiei N., Hawkins K., Whitaker I.S. Printability of pulp derived crystal, fibril and blend nanocellulose-alginate bioinks for extrusion 3D bioprinting. Biofabrication. 2019 doi: 10.1088/1758-5090/ab0631. in press. [DOI] [PubMed] [Google Scholar]
- 47.Shelke N.B., James R., Laurencin C.T., Kumbar S.G. Polysaccharide biomaterials for drug delivery and regenerative engineering. Polym. Adv. Technol. 2014;25:448–460. doi: 10.1002/pat.3266. [DOI] [Google Scholar]